Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
US11813362B2 · kind B2 · utility
0Cited by
17References
23Claims
0Family size
Inventors
Key dates
| Filing date | Jun 11, 2019 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jul 27, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention pertains to a film-coated tablet comprising an inner core and an external coating, wherein the inner core comprises a high proportion of a specific triazine derivative, namely 2-amino-3,6-dihydro-4-dimethylamino-6-methyl-1,3,5-triazine and pharmaceutically acceptable salts thereof, and a specific binder. It is also directed to the use of these tablets in the treatment of diabetes and/or complications thereof. This invention is further directed to a specific process for the manufacture of these film-coated tablets, which involves a granulation step in a high-shear mixer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.